Crotalus durissus terrificus snakes possess a protein in their blood, named crotoxin inhibitor from Crotalus serum (CICS), which protects them against crotoxin, the main toxin of their venom. CICS neutralizes the lethal potency of crotoxin and inhibits its phospholipase A 2 (PLA 2 ) activity. The aim of the present study is to investigate the specificity of CICS towards snake venom neurotoxic PLA 2 s (b-neurotoxins) and nontoxic mammalian PLA 2 s. This investigation shows that CICS does not affect the enzymatic activity of pancreatic and nonpancreatic PLA 2 s, bee venom PLA 2 and Elapidae b-neurotoxins but strongly inhibits the PLA 2 activity of Viperidae b-neurotoxins. Surface plasmon resonance and PAGE studies further demonstrated that CICS makes complexes with monomeric and multimeric Viperidae b-neurotoxins but does not interact with nontoxic PLA 2 s. In the case of dimeric b-neurotoxins from Viperidae venoms (crotoxin, Mojave toxin and CbICbII), which are made by the noncovalent association of a PLA 2 with a nonenzymatic subunit, CICS does not react with the noncatalytic subunit, instead it binds tightly to the PLA 2 subunit and induces the dissociation of the heterocomplex. In vitro assays performed with Torpedo synaptosomes showed a protective action of CICS against Viperidae b-neurotoxins but not against other PLA 2 neurotoxins, on primary and evoked liberation of acetylcholine. In conclusion, CICS is a specific PLA 2 inhibitor of the b-neurotoxins from the Viperidae family.
Snake venom phospholipases A 2 (EC 3.1.1.4) (PLA 2 ) exhibit a wide variety of pharmacological and physiopathological effects [1] . In addition to their role in the digestion of the prey, they can be neurotoxic, myotoxic, able to interfere with coagulation processes, etc. Mammalian and venom PLA 2 s have been classified into 10 different structural groups [2] . However, snake venom PLA 2 s belong only to groups I and II. Group I includes mammalian pancreatic and snake venom PLA 2 s from Elapidae and Hydrophiidae, while group II includes mammalian nonpancreatic and snake venom enzymes from Crotalidae and Viperidae.
On the other hand, several snake venom PLA 2 s evolved to become potent neurotoxins, developing selectivity for neuronal structures and recognizing specific protein acceptors. Neurotoxic PLA 2 s from snake venom, also called b-neurotoxins, cause death by respiratory failure. They act on the neuromuscular junction, primarily at a presynaptic level, inhibiting the release of neurotransmitter acetylcholine (ACh) [3±5] . The b-neurotoxins differ in their quaternary structures and three classes have been distinguished on this basis [4] . As shown in Table 1 , the first class of b-neurotoxins comprises single chain polypeptides of 13±15 kDa. It includes monomeric Elapidae b-neurotoxins, belonging to PLA 2 s group I, such as notexin (Ntx) from Notechis scutatus scutatus venom and monomeric Viperidae b-neurotoxins, belonging to PLA 2 s group II, such as agkistrodotoxin (Agtx) from Agkistrodon blomhoffii brevicaudus and ammodytoxin (Atx) from Vipera ammodytes ammodytes. The second class of b-neurotoxins (Table 1) , includes multichain neurotoxic PLA 2 s, that are made of several noncovalently linked polypeptide subunits, at least one of them being enzymatically active. This class includes multimeric Viperidae b-neurotoxins such as crotoxin (CACB) from the venom of the South-American rattlesnake Crotalus durissus terrificus, Mojave toxin from Crotalus scutelatus scutelatus venom and CbICbII from Pseudocerastes fieldi venom, which belong to PLA 2 s group II, and multimeric Elapidae bneurotoxins such as taipoxin (Tpx) from Oxyuranus scutellatus scutellatus venom which belong to PLA 2 s group I. Crotoxin is a heterodimer made of a basic and weakly toxic PLA 2 (CB) and of an acidic nontoxic and nonenzymatic subunit CA [6±11] while Tpx is composed of three PLA 2 subunits [12] . The main toxic component of Pseudocerastes fieldi venom is a neurotoxic heterodimer composed of a basic subunit CbII and an acidic subunit CbI [13] . The third class of b-neurotoxins includes b-bungarotoxin (b-Btx) from Bungarus multicinctus venom which covalently associates a PLA 2 subunit (group I of PLA 2 s) with a nontoxic polypeptide, homologous to Kunitz type serine proteinase inhibitor or dendrotoxins [14] ( Table 1) . Although b-neurotoxins belonging to different structural classes have similar electrophysiological effects on the neuromuscular junction [4] , their targets are different. High affinity binding proteins were identified in various neuronal tissues and several distinct types of PLA 2 acceptors have been proposed for neurotoxic PLA 2 s [14±22].
Venomous snakes are resistant to their own venom and several natural neutralizing proteins have been identified in their plasma [23] . In particular, PLA 2 inhibitors have been isolated from various snake sera and their primary structures have been determined [23±34]. Ohkura and coworkers [27] have classified the PLA 2 inhibitors into three distinct types (a, b and g) based on their structural characteristics.
a-type PLA 2 inhibitors include proteins such as PLI-A and PLI-B isolated from the plasma of Trimeresurus flavoviridis [24, 25] , PLIa from Agkistrodon blomhoffii siniticus [26, 27] and BaMIP from Bothrops asper [28] . They are characterized by the presence of a carbohydrate recognition domain (CRD) in their structure. They are 75±120 kDa glycoproteins noncovalently associating three or five 20±25 kDa subunits [ 24± 27] . Interestingly, these a-type inhibitors have similarities with the mammalian proteins containing C-type CRDs such as: mannose-binding protein, pulmonary surfactant protein SP-A, M-type receptor for secretory PLA 2 s [25, 32] or DEC-205 receptor expressed by dendritic cells [35] .
b-type PLA 2 inhibitors include the protein isolated from Agkistrodon blomhoffii siniticus plasma (PLIû) [27, 29] . This inhibitor is a 160-kDa glycoprotein made of three 50 kDa subunits homologous to the human leucin-rich domain of a 2 -glycoprotein [27, 29] .
g-type PLA 2 inhibitors comprise proteins isolated from Crotalus durissus terrificus [30, 31] , Naja naja kaouthia [32±33], PLIg from Agkistrodon blomhoffii siniticus [27] and PLI-I from Trimeresurus flavoviridis [34] . They are 90±130 kDa acidic glycoproteins made of the noncovalent association of three to six 24±31 kDa subunits [30±33] structurally homologous to urokinase-type plasminogen activator receptor (u-PAR) and to cell surface antigens belonging to the Ly-6 superfamily, CD59 [33] and bone specific protein called RoBo-1 [36] . Interestingly, these proteins have evolutionary relationships with`three finger' neurotoxins and cytotoxins from Elapidae snake venom [37] and xenoxins, from frog skin [38] .
In the case of Crotalus durissus terrificus snake, we previously demonstrated that its serum contains a PLA 2 inhibitor of g-type, called`crotoxin inhibitor from Crotalus serum' (CICS), that neutralizes the toxicity and inhibits the enzymatic activity of its physiological ligand crotoxin [31] . In the present work we investigate the specificity of CICS, examining its interaction with several b-neurotoxins and nontoxic secretory PLA 2 s from mammals and snake venom. This investigation indicates that CICS is a specific inhibitor of the monomeric and multimeric b-neurotoxins from Viperidae family.
M A T E R I A L S A N D M E T H O D S
Torpedo marmorata fishes were purchased from the Station de Biologie Marine (Roscoff, France) and kept alive in artificial oxygenated seawater. The fluorescent PLA 2 substrate analog: 1-palmitoyl-2-(10-pyrenyldecanoyl)-sn-glycero-3-phosphoglycerol (Pam(PyrDec)GroPGro) was obtained from Interchim (Montluc Ëon, France). Fatty acid-free bovine serum albumin, acetylcholinesterase, Luminol and ethylene-bis(oxyethylenenitrilo)tetra(acetic acid), (EGTA) were supplied by Sigma Co (St. Louis, MO, USA). Choline oxidase from Arthrobacter globiformis was purchased from Waco (Osaka, Japan). Reagents including sensor chips CM5, surfactant P20, the amine coupling kit containing N-hydroxysuccinimide (NHS), N-ethyl-N H -(3-diethylaminopropyl)carbodiimide (EDC) and ethanolamine hydrochloride were supplied by Biacore (Biacore AB, Uppsala, Sweden). All other chemicals and solvents of the highest available purity were obtained either, from Merck A.G. (Darmstad, Germany), Prolabo (Paris, France) or from Sigma Co (St. Louis, MO, USA).
CbICbII from Pseudocerastes fieldi venom was a gift from A. Bdolah (Department of Zoology, Tel Aviv University, Israel). Tpx from Oxyuranus scutelatus scutelatus venom, b-bungarotoxin and porcine pancreatic PLA 2 were purchased from Sigma. PLA 2 from Apis mellifera venom, Ntx from Notechis scutatus snake venom and Atx from Vipera ammodytes ammodytes were purchased from Latoxan (Valence, France). Recombinant human group II secretory phospholipase A 2 (hsPLA 2 ) was kindly furnished by C. Mounier [39] (Unite Â des Venins, Institut Pasteur, Paris). L. Smith (Dept. of Immunology and Mol. Biology, Fort Detrick, Frederick, USA) kindly supplied rabbit antiserum produced against Tpx and Ntx. Monoclonal antibody B-65.5 was kindly furnished by V. Choumet [40] (Unite Â des Venins, Institut Pasteur, Paris).
Purification of CICS and preparation of toxins
CICS was purified from Crotalus durissus terrificus serum and its concentrations were determined spectrophotometrically, as previously described by Perales et al. [31] . Crotoxin, its isolated subunits CA and CB and its isoforms were isolated from Crotalus durissus terrificus venom as previously reported [41, 42] . The protein concentration of crotoxin and of its isolated subunits was determined spectrophotometrically as previously reported [41] . Agtx was purified from the venom of Agkistrodon blomhoffii brevicaudus as described by Chen et al. [43] .
Preparation of anti-CICS antiserum and specific anti-CICS Ig
New Zealand white rabbits (1.5 kg body weight) were injected intradermally with 100 mg of CICS in 100 mL of 150 mm sodium chloride emulsified with 100 mL of complete Freund's adjuvant. Three subcutaneous booster injections of the same materials, in incomplete Freund's adjuvant, were given at two-week intervals. The antibody level was monitored weekly by ELISA. Antisera were collected 1±2 months after the end of immunization protocol. Specific anti-CICS immunoglobulins were purified by immunoaffinity on an AH-Sepharose 4B column coupled with CICS [44] .
Analysis of PLA 2 -CICS complexes by PAGE
The formation of the complexes was analyzed at pH 6.5 in the absence of detergent and reducing agents by PAGE in 20% acrylamide gels, using a PhastSystem (Pharmacia). CICS was incubated for 1 h at 37 8C with PLA 2 or toxins to be tested then aliquots were applied to the gel. Proteins were stained with Coomassie Brilliant blue R-250 or by immunoblotting as previously described [31] .
Analysis of PLA 2 -CICS interaction by surface plasmon resonance (SPR)
Studies were performed using a BIACOREw 2000 system (Biacore AB). The running and dilution buffer in all experiments was Hepes buffer (HBS; 10 mm Hepes, 150 mm NaCl, 3.4 mm EDTA, 0.005% surfactant P20, pH 7.4). Immobilization of anti-CICS IgG on the sensor chip surface.
Immunopurified rabbit anti-CICS IgG was covalently coupled via primary amino groups on a CM5 sensor chip surface according to Jonsson et al. [45] . Briefly, the carboxymethylated dextran matrix was activated with 30 mL of an EDC/NHS (1/1) mixture, 10 mL of rabbit anti-CICS IgG (20 mg´mL
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) in 10 mm sodium acetate (pH 4.8) were injected and unreacted groups were blocked with 30 mL ethanolamine (pH 8.5). The immobilization run was performed at a flow of 5 mL´min 21 at 25 8C. One independent flow cell of the same sensor chip was used as a control flow cell by subjecting it to a`blank immobilization', i.e. with no rabbit anti-CICS IgG added. The SPR signal for immobilized rabbit anti-CICS IgG was found to be 4047 pg´mm 22 .
CICS-PLA2 interaction. First CICS samples (30 mg´mL 21 ), and then b-neurotoxins or nontoxic PLA 2 s (0±100 mg´mL 21 ) were successively injected into the control and assay cells and their binding was monitored. Data were analyzed using the bia evaluation 2.1 software (Biacore).
Effect of CICS on the enzymatic activity of PLA 2 s
The PLA 2 activity of different neurotoxic and nontoxic secretory PLA 2 s was measured by a fluorimetric method [46] using a fluorescent labeled phospholipid analog [1Pam(PyrDec)GroPGro] as substrate. To analyze the effect of CICS on PLA 2 activity, a fixed concentration (1 mg in 20 mL NaCl/P i ) of tested PLA 2 was incubated with various concentrations of CICS at the indicated molar ratios. Incubation was carried out for 1 h at 37 8C in NaCl/P i . After 1/20 dilution, 1±10 mL, were introduced into the cuvette containing 1 mL of the fluorescent phospholipid PG (2 mm), for the measurement of PLA 2 activity.
Effect of CICS on primary and evoked Ach release induced by tested b-neurotoxins
Purely cholinergic nerve terminals (synaptosomes) were isolated from the electronic organ of Torpedo marmorata as described by Israel et al. [47] . A fixed concentration (1 mg in 20 mL NaCl/P i ) of tested b-neurotoxin was preincubated for 1 h at 37 8C with various concentrations of CICS, then aliquot (100 nm of each tested toxin) was applied to the synaptosomes for 3 min at room temperature according to the procedure previously described [48] . Primary release was triggered by the addition of Ca 21 (final concentration, 5 mm) and evoked ACh release was triggered by adding a high concentration of K 1 ions (final concentration, 90 mm) [48] and ACh was continuously monitored by the chemiluminescent technique [49] .
R E S U L T S
Interaction between CICS and neurotoxic and nontoxic PLA 2
The interaction of CICS with neurotoxic and nontoxic PLA 2 was first studied in real-time by SPR. Due to the fact that CICS is an acidic, oligomeric glycoprotein, its direct immobilization with the dextran matrix was not possible. Consequently, immunopurified anti-CICS antibodies were prepared and covalently linked to the dextran matrix. The experiments were initiated by injecting CICS, allowing it to bind to the anti-CICS antibodies. Then the PLA 2 to be tested was injected and its interaction with CICS was examined as shown in Fig. 1 .
b-Btx (class III of b-neurotoxins) and nontoxic PLA 2 s that we tested (i.e. human nonpancreatic PLA 2 , group II, porcine pancreatic PLA 2 , group I) and bee venom PLA 2 , group III were unable to interact with CICS (Fig. 1A) , even when injected at Fig. 2 ). Similarly, monomeric and multimeric b-neurotoxins from Elapidae snake family (group I PLA 2 ) did not interact with or weakly bind to CICS, as shown in Fig. 1(B) , for Tpx and Ntx. On the other hand, b-neurotoxins from Viperidae snake family (group II PLA 2 ) strongly associated to CICS. These interactions were examined in detail in the case of crotoxin and CbICbII and of their isolated subunits (Fig. 1C±F) . Monomeric b-neurotoxins from Viperidae, Atx and Agtx less effectively bound to CICS than the isolated PLA 2 subunits of multimeric b-neurotoxins from Viperidae (Fig. 1C) . Basic subunit CB alone, as well as associated to CA in crotoxin interacted with CICS, while acidic subunit CA alone did not bind to CICS (Fig. 1E) . The same behavior was observed in the case of CbICbII where only basic subunit CbII and whole toxin associated with CICS (Fig. 1F) . Furthermore, SPR experiments performed with a monoclonal antibody directed against the catalytic subunit CB of crotoxin demonstrated that the PLA 2 subunit remains bound to CICS (Fig. 2) . A quantitative study ( Table 2 , Fig. 1D ) determined the kinetic parameters of the interaction between CICS and crotoxin: the dissociation rate constant k off 1.7 Â 10 24 s
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, the association rate constant k on 1.3 Â 10 4 m 21´s21 and the apparent dissociation constant K app d k off /k on of 13 nm. Similar kinetic parameters were observed with CbICbII and Table 3 . Effect of CICS on ACh release induced by b-neurotoxins on Torpedo synaptosomes. A fixed concentration of tested b-neurotoxin (1 mg in 20 mL NaCl/P i ) was incubated for 1 h at 37 8C with the indicated molar excess of CICS, then the aliquot (100 nm) was applied to the synaptosomes for 3 min at room temperature. ACh release was triggered by the addition of 5 mm CaCl 2 toxin Mojave (results not shown). Interestingly, the PLA 2 subunits (CB, CB Mojave and CbII) when isolated from their complexes bind to CICS with a 10-fold increase in k on and a nearly 10-fold increase in k off , leading to a similar K d app ( Table 2) . PAGE was used to analyze further the formation of complexes between CICS and b-neurotoxins. The various b-neurotoxins were preincubated with CICS, then submitted to PAGE and the gels were stained with Coomassie blue. Almost all tested monomeric (class I) and multimeric (class II) b-neurotoxins from Viperidae venom (PLA 2 group II, Table 1 ) or their isolated PLA 2 subunits formed complexes with CICS, characterized by a slower mobility than that of CICS alone (results not shown), as previously reported in the case of crotoxin [31] . However, this reduction in the mobility of CICS in the presence of Agtx, Ntx and Tpx was not detected and the composition of possible toxin-inhibitor complexes was further analyzed by Westernblot using polyclonal antibody anti-Agtx, anti-Ntx and anti-Tpx (Fig. 3 ). Westernblot performed with polyclonal antibodies directed against Agtx (Fig. 3A , panel 2 BLOT) shows that anti-Agtx detected free Agtx and also Agtx present in a protein band that migrates at CICS position. This indicates that this band is in fact a complex made of CICS and of Agtx. This complex co-migrates with CICS because the molecular mass/electric charge ratio of the CICS-Agtx complex is therefore very similar to that of CICS (we performed PAGE in the absence of SDS and reducing agents). In the case of the experiments performed with Ntx, free Ntx (very basic and hydrophobic protein) remains in the stacking gel (Fig. 3B,  panel 3 PAGE) . It cannot therefore be detected by Westernblot because the stacking zone cannot be removed from the solid support used to performed PAGE (Fig. 3B, panel 3 BLOT) . The proportion of free Ntx and Ntx in a complex with CICS can be determined from a full panel (positions 2 and 3 PAGE) after staining with Coomassie blue. Free Ntx which remains in the stacking zone (Fig. 3B, panel 3 PAGE) was not detected in this zone after incubation with CICS (Fig. 3B, panel 2 PAGE) . We conclude therefore that the majority of Ntx is present in the complex and this was confirmed with anti-Ntx antibodies where a new band corresponding to CICS/Ntx complex was labeled (Fig. 3B, panel 2 BLOT) . On the other hand SPR experiments showed a very small signal of association of Ntx with CICS, most probably because these experiments were performed in the presence of 0.005 % polysorbate 20 (v/v) which reduce the formation of hydrophobic complexes. In contrast, the anti-Tpx antibody only detected free Tpx and no complex between CICS and Tpx can be labeled with anti-Tpx antibodies (Fig. 3C, panel 
BLOT). In agreement with BIACORE
w results, incubation between CICS and a multimeric Elapidae b-neurotoxin did not produce any complex.
Effect of CICS on the enzymatic activity of nontoxic PLA 2 and b-neurotoxins
The PLA 2 activity was measured by recording the changes in fluorescence intensity following hydrolysis of a substrate analogue. No significant change was observed in enzymatic activity of nontoxic secretory PLA 2 s (porcine pancreatic PLA 2 , group I; hsPLA 2 , group II and bee venom PLA 2 , group III), preincubated and tested in the presence of CICS (Fig. 4A) . A similar lack of effect was observed with Elapidae b-neurotoxins (PLA 2 group I) i.e. (monomeric Ntx (class I), multimeric Tpx (class II) and b-Btx (class III) (Fig. 4B) . On the other hand, mono and multimeric b-neurotoxins from Viperidae (group II PLA 2 ) were strongly inhibited by CICS, as well as their isolated enzymatic subunit. As shown in Fig. 4C , the PLA 2 activity of Agtx, CB, CB Mojave and CbII was reduced to 55 %, 90 %, 80 % and 70 %, respectively, in the presence of a twofold molar excess of CICS, while an eightfold molar excess of CICS is required for 80 % inhibition in the case of crotoxin, CbICbII and Mojave toxin (Fig. 4C) .
Effect of CICS on the pharmacological properties of b-neurotoxins
Synaptosomes isolated from the electric organ of Torpedo marmorata provided a purely cholinergic model of the presynaptic part of the neuromuscular junction to study the neurotoxic action of b-neurotoxins. These isolated nerve terminals were still able to respond to depolarization with high concentrations of K 1 ions (90 mm) by releasing ACh. CICS alone did not affect this physiological response (Table 3 ). In the presence of Ca 12 (5 mm), b-neurotoxins induce a dose-dependent primary ACh release from synaptosomes [48] . When tested b-neurotoxins were incubated for 1 h with increasing amounts of CICS and compared to the control (the same b-neurotoxin without CICS), a dose dependent inhibition of primary ACh release was observed (data not shown). This release was almost totally prevented after preincubation of multimeric Viperidae b-neurotoxins or of their PLA 2 subunits with CICS at the molar ratio of 1/16 (toxin/inhibitor) ( Table 3) . This inhibitory effect of CICS on primary ACh release induced by Elapidae b-neurotoxins was less evident (Table 3) .
After treatment with b-neurotoxins Torpedo synaptosomes were also tested for their ability to release ACh on depolarization by 90 mm KCl. As shown in Table 3 , the crotoxin and CbICbII (100 nm) affected the release of ACh, by reducing their ability to respond to high K 1 levels. This reduction was inverted after application of increasing amounts of CICS. In the case of Elapidae b-neurotoxins that weakly reduced K 1 evoked ACh release, CICS did not affect this response.
D I S C U S S I O N
Three types of PLA 2 -inhibitors (a, b and g) were described in the serum of various snakes. Numerous studies demonstrated their protective role against the PLA 2 s of their own venom but their specificity for nontoxic and neurotoxic PLA 2 s has not yet been well investigated. In this study we analyzed the specificity of CICS for neurotoxic and nontoxic secretory PLA 2 s and examined the molecular mechanism of the interactions between CICS and neurotoxins belonging to the three structural groups of b-neurotoxins.
Our results show that CICS, which presents a sequence homology with neurotoxin-like inhibitors and therefore belonging to the g-type PLA 2 inhibitors [33] , exhibits a pattern of PLA 2 inhibition different from other members of this inhibitor family. In fact, CICS inhibits the PLA 2 activity and neutralizes the pharmacological action of crotoxin, the main neurotoxin from Crotalus durissus terrificus venom. It also inhibits and neutralizes other monomeric and multimeric PLA 2 b-neurotoxins from Viperidae snake venom, but does not act on PLA 2 b-neurotoxins from Elapidae venom or the toxic or nontoxic PLA 2 s from other sources. This observation is in accordance with the recent report of Fortes-Dias et al. [50] , showing that CNF (CNF and CICS being different denominations of the same protein) is able to inhibit several PLA 2 s isolated from the venom of the Viperidae snake Lachesis muta muta. Our conclusion contrasts, however, with the wider specificity of the other members of the g type family of PLA 2 inhibitors. For example, it has been reported that the PLA 2 inhibitor isolated from the Elapidae (Naja naja kaouthia) plasma and PLIg isolated from Agkistrodon blomhoffii siniticus plasma not only inhibited PLA 2 s from their own venoms but also PLA 2 s from other sources and belonging to groups I, II and III [27, 33] . In a previous investigation [31] we suggested that CICS might be used as an alternative to horse antiserum in the antivenin treatment of human envenomations by Crotalus durissus terrificus. Because of its larger specificity, CICS might be therefore useful in the treatment of envenomations by all the Viperidae snakes. In this context, it is important to note that CICS has no effect on mammalian pancreatic (group I) and mammalian nonpancreatic (group II) PLA 2 s, indicating that it should not interfere with the biological function of these human enzymes.
In this investigation, we further demonstrated using PAGE and SPR that CICS forms complexes with PLA 2 subunits of multimeric toxins such as CbII from CbICbII, CB Mojave from Mojave toxin and CB from crotoxin. The PLA 2 subunits were very sensitive to CICS. The isolated PLA 2 subunits bind to CICS more rapidly than the whole complex (the k on value was found to be 10-fold higher). In agreement with the former, only a twofold molar excess of CICS is sufficient for almost total inhibition of the PLA 2 activity of PLA 2 subunits, while an eightfold molar excess is required for the same level of inhibition in the case of whole toxin. Further, SPR experiments performed with monoclonal antibodies specific for the catalytic subunit of b-neurotoxins showed that this subunit remains bound to CICS (Fig. 2) . This observation is in agreement with previous results showing that CICS induces the dissociation of multimeric b-neurotoxins, the PLA 2 subunit remaining bound to CICS [31] . This dissociation of the complex explains how CICS neutralizes the neurotoxicity of these multimeric toxins. A similar mechanism has been described with a monoclonal antibody, A-56.36, directed to the CA subunit of crotoxin which neutralizes the lethal potency of crotoxin by dissociating the complex [51] . However, it should be emphasized that, at variance with CICS, the monoclonal antibody interacts with CA subunit releasing the CB subunit into solution which is less toxic than the whole crotoxin. Therefore, because of the residual toxicity of CB, the mechanism of neutralization by CICS is more efficient than that obtained with the monoclonal antibody A-56. 36 .
We observed a strong protective effect of CICS against the neurotoxic action of b-neurotoxins from Viperidae venoms on primary and evoked ACh release from Torpedo synaptosomes. b-neurotoxins cause a PLA 2 dependent primary release of ACh and the partial blockage of K 1 -evoked ACh release on isolated nerve terminals from the electric organ of Torpedo [48] . As shown in Table 3 , CICS inhibited the primary effect of Viperidae b-neurotoxins and also inhibited their blockage of K 1 -evoked ACh release. This inhibition by CICS of the in vitro effect of Viperidae b-neurotoxins could correspond to its neutralizing effect demonstrated in vivo by lethality assays, in the case of crotoxin [31] . A possible explanation for the protective effect of CICS might be that it behaves as a false soluble receptor for b-neurotoxins, preventing their binding to their pharmacologically active receptors on synaptosomes, as previously suggested [31] . In contrast with PLA 2 b-neurotoxins from Viperidae, we did not observe any inhibitory action of CICS either on the enzymatic or the pharmacological activities of PLA 2 b-neurotoxins from Elapidae venoms. The functional activity of Ntx-CICS complex is not biologically relevant as Ntx remains enzymatically and pharmacologically active in the complex.
In conclusion, CICS specifically inhibits monomeric and multimeric b-neurotoxins from Viperidae family. The formation of PLA 2 -CICS complexes is responsible for the inhibition of PLA 2 activity and for the protective effect of CICS against the neurotoxic action of these b-neurotoxins.
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